New Zealand
What lies ahead for New Zealand’s medical device market?
A shift in policy involves decreased funding for digital health, impacting the sector’s growth.
What lies ahead for New Zealand’s medical device market?
A shift in policy involves decreased funding for digital health, impacting the sector’s growth.
New Zealand’s HIV tests market set for growth at 2% CAGR until 2033
EIA tests accounted for around 49% of the country’s HIV test market in 2023.
New Zealand’s medicines budget to boost R&D-based drugmakers
But Fitch Solutions’ report noted that allocation for medicine investment remains low.
New Zealand rolls out health system reforms
Its healthcare system was criticized over variable access across districts.
Private operator Healthscope sells New Zealand pathology business for $364m
Customary approval is expected to be completed within the next six months.